Fiebre maculosa de las Montañas Rocosas en niños y adolescentes mexicanos: Cuadro clínico y factores de mortalidad

Gerardo Álvarez-Hernández*, María del Carmen Candia-Plata, Jesús Delgado-de la Mora, Natalia Haydeé Acuña-Meléndrez, Anabel Patricia Vargas-Ortega, Jesús David Licona-Enríquez

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

17 Citas (Scopus)

Resumen

Objective: Characterize clinical manifestations and predictors of mortality in children hospitalized for spotted fever. Materials and methods: Cross-sectional study in 210 subjects with a diagnosis of Rocky Mountain spotted fever (RMSF) in a pediatric hospital in Sonora, from January 1st, 2004 to June 30th, 2015. Data were analyzed using descriptive statistics and multivariate logistic regression. Results: An upward trend was observed in RMSF morbidity and mortality. Fatality rate was 30%. Three predictors were associated with risk of death: delay ≥ 5 days at the start of doxycycline (ORa = 2.95, 95% CI 1.10-7.95), acute renal failure ((ORa = 8.79, 95% CI 3.46-22.33) and severe sepsis (ORa = 3.71, 95% CI 1.44-9.58). Conclusions: RMSF causes high mortality in children, which can be avoided with timely initiation of doxycycline. Acute renal failure and severe sepsis are two independent predictors of death in children with RMSF.

Título traducido de la contribuciónRocky Mountain spotted fever in Mexican children: Clinical and mortality factors
Idioma originalEspañol
Páginas (desde-hasta)385-392
Número de páginas8
PublicaciónSalud publica de Mexico
Volumen58
N.º3
DOI
EstadoPublicada - 2016

Palabras clave

  • Adolescents
  • Children
  • Mexico
  • Rocky mountain spotted fever

Huella

Profundice en los temas de investigación de 'Fiebre maculosa de las Montañas Rocosas en niños y adolescentes mexicanos: Cuadro clínico y factores de mortalidad'. En conjunto forman una huella única.

Citar esto